NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $29.71 -0.68 (-2.23%) Closing price 05/28/2025 03:59 PM EasternExtended Trading$29.71 0.00 (0.00%) As of 05/28/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About USANA Health Sciences Stock (NYSE:USNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get USANA Health Sciences alerts:Sign Up Key Stats Today's Range$29.68▼$30.4550-Day Range$23.51▼$30.4052-Week Range$23.10▼$49.16Volume115,917 shsAverage Volume133,106 shsMarket Capitalization$553.31 millionP/E Ratio10.50Dividend YieldN/APrice Target$36.00Consensus RatingHold Company OverviewUSANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.Read More… USANA Health Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks81st Percentile Overall ScoreUSNA MarketRank™: USANA Health Sciences scored higher than 81% of companies evaluated by MarketBeat, and ranked 151st out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingUSANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageUSANA Health Sciences has received no research coverage in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Earnings and Valuation4.4 / 5Proj. Earnings Growth17.96% Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 17.96% in the coming year, from $2.45 to $2.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 10.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.80.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 10.50, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.88.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about USANA Health Sciences' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.58% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 4.82%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Sustainability and ESG3.2 / 5Environmental Score-2.09 Percentage of Shares Shorted8.58% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 4.82%, indicating that investor sentiment is decreasing. News and Social Media2.1 / 5News Sentiment0.83 News SentimentUSANA Health Sciences has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for USANA Health Sciences this week, compared to 4 articles on an average week.Search Interest1 people have searched for USNA on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $633,132.00 in company stock.Percentage Held by InsidersOnly 0.63% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address USNA Stock News HeadlinesUSANA Health Sciences, Inc. (NYSE:USNA) CFO Sells $134,666.28 in StockMay 13, 2025 | insidertrades.comUSANA Health Sciences (NYSE:USNA) Stock Rating Upgraded by Wall Street ZenMay 25, 2025 | americanbankingnews.comJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.May 29, 2025 | Premier Gold Co (Ad)Shareholders in USANA Health Sciences (NYSE:USNA) are in the red if they invested five years agoMay 21, 2025 | finance.yahoo.comUSNA Q1 Earnings Call: Product Expansion and Market Momentum Drive OutperformanceMay 13, 2025 | finance.yahoo.comUSANA Releases 2024 Sustainability ReportMay 8, 2025 | prnewswire.comKevin Guest Shares Transformative Success Strategies on Executive Coaching Day, May 1May 1, 2025 | prnewswire.comUSANA Celavive Postbiotic Rescue Serum Selected as a Good Housekeeping 2025 Beauty Award WinnerApril 28, 2025 | prnewswire.comSee More Headlines USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $35.89 at the beginning of 2025. Since then, USNA stock has decreased by 17.2% and is now trading at $29.7110. View the best growth stocks for 2025 here. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) released its earnings results on Tuesday, April, 22nd. The company reported $0.73 EPS for the quarter, beating the consensus estimate of $0.70 by $0.03. The company earned $249.54 million during the quarter, compared to the consensus estimate of $243.08 million. USANA Health Sciences had a trailing twelve-month return on equity of 10.64% and a net margin of 6.30%. Read the conference call transcript. Who are USANA Health Sciences' major shareholders? Top institutional shareholders of USANA Health Sciences include Vanguard Group Inc. (7.38%), Pzena Investment Management LLC (5.81%), American Century Companies Inc. (1.37%) and Jacobs Levy Equity Management Inc. (1.01%). Insiders that own company stock include Myron W Wentz, Jim Brown, David Mulham Mulham, Kevin Guest, John Turman Fleming, Peggie Pelosi, Frederic J Winssinger, Xia Ding, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX). Company Calendar Last Earnings4/22/2025Today5/28/2025Next Earnings (Estimated)7/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medicinals & botanicals Sub-IndustryPersonal Products Current SymbolNYSE:USNA CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,900Year FoundedN/APrice Target and Rating Average Stock Price Target$36.00 High Stock Price Target$36.00 Low Stock Price Target$36.00 Potential Upside/Downside+21.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$1.82 Trailing P/E Ratio10.50 Forward P/E Ratio12.13 P/E Growth0.93Net Income$63.79 million Net Margins6.30% Pretax Margin10.73% Return on Equity10.64% Return on Assets8.48% Debt Debt-to-Equity RatioN/A Current Ratio3.93 Quick Ratio3.37 Sales & Book Value Annual Sales$876.24 million Price / Sales0.63 Cash Flow$4.08 per share Price / Cash Flow7.29 Book Value$25.99 per share Price / Book1.14Miscellaneous Outstanding Shares18,623,000Free Float18,997,000Market Cap$553.31 million OptionableOptionable Beta0.60 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NYSE:USNA) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.